analyst
OL
NASDAQ · OLMA
Olema Pharmaceuticals, Inc.
Healthcare · Biotechnology
$9.78
Down-$0.13 (-1.33%)
Updated Sep 16, 2026, 3:14 PM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.17B
- P/E ratio
- -18.05
- Dividend yield
- 0.00%
- 52-week range
- $6.65 – $36.26
- Volume
- 1.73M
- Avg. volume
- 3.41M
Price performance
OLMA price history
1M range · 20 trading sessions · Daily adjusted prices
OLMA closed at $9.78 after 20 trading sessions, down 8.17% for the selected period.
- Last close
- $9.78
- Period change
- -8.17%
- Period low
- $9.78
- Period high
- $11.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $10.29 | $10.34 | $9.65 | $9.78 | 1.73M |
| Sep 14, 2026 | $9.99 | $10.37 | $9.79 | $10.29 | 1.82M |
| Sep 11, 2026 | $10.79 | $10.86 | $10.18 | $10.22 | 1.01M |
| Sep 10, 2026 | $10.19 | $10.98 | $10.11 | $10.69 | 1.12M |
| Sep 9, 2026 | $11.13 | $11.18 | $10.35 | $10.36 | 863.84K |
| Sep 8, 2026 | $10.61 | $11.055 | $10.46 | $10.985 | 736.72K |
| Sep 4, 2026 | $10.61 | $10.85 | $10.57 | $10.75 | 505.27K |
| Sep 3, 2026 | $10.71 | $10.98 | $10.58 | $10.73 | 773.32K |
| Sep 2, 2026 | $10.58 | $11.02 | $10.475 | $10.83 | 866.43K |
| Sep 1, 2026 | $10.36 | $10.63 | $10.28 | $10.56 | 766.11K |
| Aug 31, 2026 | $10.20 | $10.53 | $10.0859 | $10.43 | 937.03K |
| Aug 28, 2026 | $10.69 | $10.77 | $10.19 | $10.27 | 740.85K |
| Aug 27, 2026 | $10.70 | $10.92 | $10.62 | $10.79 | 383.35K |
| Aug 26, 2026 | $10.78 | $10.965 | $10.575 | $10.85 | 472.34K |
| Aug 25, 2026 | $10.60 | $11.02 | $10.595 | $10.91 | 799.92K |
| Aug 24, 2026 | $10.58 | $10.62 | $10.29 | $10.43 | 727.33K |
| Aug 21, 2026 | $10.90 | $11.24 | $10.65 | $10.69 | 748.7K |
| Aug 20, 2026 | $11.10 | $11.12 | $10.67 | $10.90 | 1.04M |
| Aug 19, 2026 | $10.90 | $11.36 | $10.765 | $11.31 | 1.76M |
| Aug 18, 2026 | $10.69 | $10.88 | $10.51 | $10.65 | 960.52K |
Latest OLMA news
The latest Smart Investors Daily articles mentioning OLMA.
Stock researchResearch & News · SEC Filings
Loading stock research…